Avantax Planning Partners, Inc. Thermo Fisher Scientific Inc. Transaction History

Avantax Planning Partners, Inc.

  • $2.78 Billion
  • Q3 2024

A detailed history of Avantax Planning Partners, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Avantax Planning Partners, Inc. holds 5,443 shares of TMO stock, worth $2.88 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,443
Previous 6,880 20.89%
Holding current value
$2.88 Million
Previous $3.8 Million 11.51%
% of portfolio
0.12%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$531.86 - $624.21 $764,282 - $896,989
-1,437 Reduced 20.89%
5,443 $3.37 Million
Q2 2024

Aug 09, 2024
SELL
$541.52 - $599.02 $2.67 Million - $2.95 Million
-4,926 Reduced 41.72%
6,880 $3.8 Million
Q1 2024

May 02, 2024
BUY
$528.82 - $599.43 $124,272 - $140,866
235 Added 2.03%
11,806 $6.86 Million
Q4 2023

Feb 09, 2024
BUY
$431.41 - $532.94 $121,657 - $150,289
282 Added 2.5%
11,571 $6.14 Million
Q3 2023

Nov 03, 2023
SELL
$498.29 - $574.41 $533,668 - $615,193
-1,071 Reduced 8.67%
11,289 $5.71 Million
Q2 2023

Jul 17, 2023
BUY
$508.46 - $591.13 $216,603 - $251,821
426 Added 3.57%
12,360 $6.45 Million
Q1 2023

Apr 20, 2023
SELL
$535.0 - $604.82 $114,490 - $129,431
-214 Reduced 1.76%
11,934 $6.88 Million
Q4 2022

Feb 09, 2023
SELL
$484.71 - $571.37 $94,033 - $110,845
-194 Reduced 1.57%
12,148 $6.69 Million
Q3 2022

Oct 14, 2022
BUY
$507.19 - $604.49 $81,657 - $97,322
161 Added 1.32%
12,342 $6.26 Million
Q2 2022

Jul 18, 2022
SELL
$500.9 - $612.21 $4.14 Million - $5.06 Million
-8,269 Reduced 40.44%
12,181 $6.62 Million
Q1 2022

May 09, 2022
SELL
$524.0 - $644.92 $228,988 - $281,830
-437 Reduced 2.09%
20,450 $12.1 Million
Q4 2021

Jan 28, 2022
BUY
$569.0 - $667.24 $52,917 - $62,053
93 Added 0.45%
20,887 $13.9 Million
Q3 2021

Oct 27, 2021
BUY
$509.53 - $609.78 $11,719 - $14,024
23 Added 0.11%
20,794 $11.9 Million
Q2 2021

Aug 10, 2021
BUY
$441.0 - $508.24 $426,006 - $490,959
966 Added 4.88%
20,771 $10.5 Million
Q1 2021

May 06, 2021
SELL
$439.85 - $518.83 $140,752 - $166,025
-320 Reduced 1.59%
19,805 $9.04 Million
Q4 2020

Feb 04, 2021
SELL
$435.06 - $527.66 $194,471 - $235,864
-447 Reduced 2.17%
20,125 $9.37 Million
Q3 2020

Oct 28, 2020
SELL
$359.77 - $441.52 $101,455 - $124,508
-282 Reduced 1.35%
20,572 $9.08 Million
Q2 2020

Jul 15, 2020
SELL
$275.2 - $362.34 $98,246 - $129,355
-357 Reduced 1.68%
20,854 $7.56 Million
Q1 2020

Apr 27, 2020
BUY
$255.3 - $340.05 $417,415 - $555,981
1,635 Added 8.35%
21,211 $6.02 Million
Q4 2019

Jan 15, 2020
BUY
$271.93 - $328.04 $183,008 - $220,770
673 Added 3.56%
19,576 $6.36 Million
Q3 2019

Nov 08, 2019
BUY
$268.46 - $305.43 $30,872 - $35,124
115 Added 0.61%
18,903 $5.51 Million
Q2 2019

Aug 07, 2019
SELL
$257.51 - $295.55 $183,089 - $210,136
-711 Reduced 3.65%
18,788 $5.6 Million
Q1 2019

May 08, 2019
SELL
$212.17 - $273.72 $91,233 - $117,699
-430 Reduced 2.16%
19,499 $5.34 Million
Q4 2018

Feb 14, 2019
BUY
$208.47 - $251.98 $29,602 - $35,781
142 Added 0.72%
19,929 $4.46 Million
Q3 2018

Nov 13, 2018
BUY
$205.57 - $244.32 $85,517 - $101,637
416 Added 2.15%
19,787 $4.83 Million
Q2 2018

Aug 13, 2018
SELL
$203.14 - $219.53 $932,615 - $1.01 Million
-4,591 Reduced 19.16%
19,371 $4.01 Million
Q1 2018

May 15, 2018
BUY
$192.98 - $224.11 $3,087 - $3,585
16 Added 0.07%
23,962 $4.95 Million
Q4 2017

Feb 09, 2018
SELL
$182.03 - $200.37 $83,733 - $92,170
-460 Reduced 1.88%
23,946 $4.55 Million
Q3 2017

Oct 19, 2017
BUY
$171.74 - $194.04 $4.19 Million - $4.74 Million
24,406
24,406 $4.62 Million

Others Institutions Holding TMO

# of Institutions
2,835
Shares Held
333M
Call Options Held
2.37M
Put Options Held
2.75M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Avantax Planning Partners, Inc. Portfolio

Follow Avantax Planning Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Planning Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Planning Partners, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email